cas 7126-39-8|| where to buy 1H-Pyrrole-3-carbaldehyde

Nombre del producto:1H-Pyrrole-3-carbaldehyde

IUPAC Name:1H-pyrrole-3-carbaldehyde

Unidad de embalaje	Stock disponible	Precio($)
CM198450-5g	in stock	ƩǺ
CM198450-10g	in stock	ƻșǺ
CM198450-25g	in stock	ŭƻş
CM198450-100g	in stock	şƏǠ

Sólo para uso en I+D..

Formulario de consulta

Nombre químico

Número CAS

Cantidad*

Especificaciones requeridas*
(% de ensayo, grado de material, etc.)

Nombre de contacto*

Correo electrónico de contacto*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 7126-39-8 regularly via the above email.

Notas adicionales

Verification code*

refresh

: Núm. De CAS :7126-39-8; Fórmula molecular:C5H5NO; Punto de fusión:-; Código de sonrisas:O=CC1=CNC=C1; Densidad:

: Número de catálogo:CM198450; Peso molecular:95.1; Punto de ebullición:; Nº Mdl:MFCD03426733; Almacenamiento:Keep in Inert atmosphere, store at 2-8°C.

: Pyrroles; Pyrrole is a five membered heterocyclic compound with the molecular formula of C4H5N. Pyrrole has a ring composed of four carbon atoms and one nitrogen atom. Pyrrole is easy to polymerize in the air. Pyrrole is the parent compound of many important biological substances (such as bile pigment, porphyrin and chlorophyll). Pyrrole scaffolds are widely used in biological and pharmaceutical fields. Pyrrole is a special heterocyclic scaffold, which exists in many natural products, drug molecules and pesticides, and has shown its application in materials science.; Pyrrole,Where to Buy Pyrroles-Chemenu; Pyrrole,Where to Buy Pyrroles; Pyrrole is a heterocyclic, aromatic, organic compound, a five-membered ring with the formula C 4H 4NH. It is a colorless volatile liquid that darkens readily upon exposure to air. Substituted derivatives are also called pyrroles, e.g., N-methylpyrrole.

: Vonoprazan; Nov. 01, 2023, FDA has approved VOQUEZNA (vonoprazan) tablets, a novel potassium-competitive acid blocker (PCAB), as a new treatment for adults for the healing of all grades of Erosive Esophagitis, also known as Erosive GERD (gastroesophageal reflux disease).
PCABs are a novel class of medicines that block acid secretion in the stomach, and VOQUEZNA is the first PCAB to be approved in the U.S. Vonoprazan has shown the potential to provide acid suppression that can achieve pH levels that are important in enhancing treatment effectiveness.